K KNACK PHARMACEUTICALS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87818037
Serial Number
87818037
Registration Number
6540125
Word Mark
K KNACK PHARMACEUTICALS
Status
700 - Registered
Status Date
2021-10-26
Filing Date
2018-03-02
Registration Number
6540125
Registration Date
2021-10-26
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
090104, 240708, 260902, 270104, 270301 - Ribbons, bows. Ribbons to raise awareness or support for causes. Plain single line squares. Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps. Geometric figures forming letters or numerals, including punctuation.
Published for Opposition Date
2018-07-24
Attorney Name
Tomas Maria Casalins
Law Office Assigned Location Code
L10
Employee Name
MAYES, LAURIE ANN
Statements
Indication of Colors claimed
The color(s) blue, white and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMACEUTICALS"
Description of Mark
The mark consists of the word "KNACK" in a stylized blue font in all uppercase letters, beneath which lies the word "PHARMACEUTICALS" in a second smaller stylized font in gray, to the left of which lies a stylized dark blue ribbon shape oriented horizontally with the legs of the ribbon extending outwards toward the right edge of the ribbon, with a light blue bar bisecting the top part of the ribbon, with the two stylized geometric shapes together comprising a stylized letter "K". Inside the "K" is a white diamond shape. Together the three literal elements form the combined phrase "K KNACK PHARMACEUTICALS".
Goods and Services
Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of epilepsy disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of Alzheimer; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of toxic effects; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for the prevention and treatment of hormone disorders and deficiencies; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of nausea and vomiting; Pharmaceutical preparations for the prevention and treatment of aids-related disorders and diseases; Pharmaceutical preparations for treatment and prevention of viral and bacterial infections; Pharmaceutical preparations, namely, injectable contraceptives
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-03-09
Primary Code
005
First Use Anywhere Date
2021-08-01
First Use In Commerce Date
2021-08-01
Current Trademark Owners
Party Name
KNACK PHARMACEUTICALS, INC.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
KNACK PHARMACEUTICALS, INC.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
KNACK PHARMACEUTICALS, INC.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
KNACK PHARMACEUTICALS, INC.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Tomas Maria Casalins
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-03-06NEW APPLICATION ENTERED IN TRAM
2018-03-09NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-03-10NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-06-13ASSIGNED TO EXAMINER
2018-06-14EXAMINERS AMENDMENT -WRITTEN
2018-06-14EXAMINERS AMENDMENT E-MAILED
2018-06-14NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2018-06-15ASSIGNED TO LIE
2018-06-15EXAMINER'S AMENDMENT ENTERED
2018-06-18EXAMINERS AMENDMENT -WRITTEN
2018-06-18EXAMINERS AMENDMENT E-MAILED
2018-06-18NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2018-06-18EXAMINER'S AMENDMENT ENTERED
2018-06-18APPROVED FOR PUB - PRINCIPAL REGISTER
2018-06-19LAW OFFICE PUBLICATION REVIEW COMPLETED
2018-07-04NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-07-24PUBLISHED FOR OPPOSITION
2018-07-24OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-09-18NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-03-04TEAS EXTENSION RECEIVED
2019-03-04EXTENSION 1 FILED
2019-03-04EXTENSION 1 GRANTED
2019-03-06NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-08-28TEAS EXTENSION RECEIVED
2019-08-28EXTENSION 2 FILED
2019-08-28EXTENSION 2 GRANTED
2019-08-30NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-03-05TEAS EXTENSION RECEIVED
2020-03-05EXTENSION 3 FILED
2020-03-05EXTENSION 3 GRANTED
2020-03-07NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-08-06TEAS EXTENSION RECEIVED
2020-08-06EXTENSION 4 FILED
2020-08-06EXTENSION 4 GRANTED
2020-08-08NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-03-02TEAS EXTENSION RECEIVED
2021-03-16CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-03-02EXTENSION 5 FILED
2021-03-16EXTENSION 5 GRANTED
2021-03-17NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-09-10TEAS STATEMENT OF USE RECEIVED
2021-09-10USE AMENDMENT FILED
2021-09-17STATEMENT OF USE PROCESSING COMPLETE
2021-09-17ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2021-09-18NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2021-10-26REGISTERED-PRINCIPAL REGISTER
2021-11-17TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-11-17ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-11-17TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2021-11-17TEAS CHANGE OF CORRESPONDENCE RECEIVED